Griffith & Werner’s AbbVie ABBV Stock Holding History

Griffith & Werner’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.71M	Buy	14,738 +1,161	+9%	+$250K	1.74%	25
2026 Q1	$2.95M	Buy	13,577 +1,397	+11%	+$310K	1.46%	28
2025 Q4	$2.78M	Buy	12,180 +134	+1%	+$30.5K	1.42%	26
2025 Q3	$2.63M	Buy	+12,046	New	+$2.45M	1.36%	26
2025 Q1	$2.4M	Buy	11,447 +621	+6%	+$121K	1.49%	26
2024 Q4	$1.92M	Buy	+10,826	New	+$1.99M	1.27%	28

Other funds holding ABBV

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

ECSS

Eurizon Capital SGR SpA Milan $37.3B AUM

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Griffith & Werner's ABBV Position: Q2 2026 in Review

Griffith & Werner increased its AbbVie (ABBV) stake by 8.6% in Q2 2026, buying an estimated $250K and bringing the position to 14,738 shares worth $3.71M. The position accounts for 1.74% of the portfolio, ranked #25.

Griffith & Werner first reported a position in ABBV in Q4 2024 and has held it in 6 quarters since. 2,121 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Griffith & Werner held 14,738 shares of AbbVie worth $3.71M as of Q2 2026.
Griffith & Werner bought 1,161 AbbVie shares in Q2 2026, an estimated $250K.
AbbVie made up 1.74% of Griffith & Werner's portfolio in Q2 2026, its #25 holding.
Griffith & Werner first reported a position in AbbVie in Q4 2024 and has held it in 6 quarters since.
2,121 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Griffith & Werner's 13F filing for Q2 2026, filed 30 Jul 2026.